TrialPanorama/TrialPanorama-database huggingface dataset:
Study 32780725 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 32780846 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 32780846 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 32780846 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32780846 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32781244 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32781527 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study 32781527 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 32781541 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study 32785569 — Predictive Biomarker (PRD): STC1 mRNA
Genes: STC1; STC
Study 32785680 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32785820 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 32787449 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32787449 — Predictive Biomarker (PRD): Hormone receptor
Study 32788687 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study 32789591 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32789591 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32790018 — Predictive Biomarker (PRD): RPS20 mRNA
Genes: RPS20
Study 32790018 — Predictive Biomarker (PRD): RPL22 mRNA
Genes: RPL22
Study 32791423 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 32792436 — Predictive Biomarker (PRD): UST mRNA
Genes: UST; DS2ST
Study 32792436 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32796254 — Predictive Biomarker (PRD): ACSL5 mRNA
Genes: ACSL5; ACS5; FACL5; UNQ633/PRO1250
Study 32796254 — Predictive Biomarker (PRD): ACSL1 mRNA
Genes: ACSL1; FACL1; FACL2; LACS; LACS1; LACS2
Study 32796254 — Predictive Biomarker (PRD): ACSL6 mRNA
Genes: ACSL6; ACS2; FACL6; KIAA0837; LACS5
Study 32796418 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 32799568 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 32800518 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 32801120 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 32801129 — Predictive Biomarker (PRD): GLS2 mRNA
Genes: GLS2; GA
Study 32801289 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 32802114 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 32802401 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 32802883 — Predictive Biomarker (PRD): CX3CR1 mRNA
Genes: CX3CR1; CMKBRL1; GPR13
Study 32802883 — Predictive Biomarker (PRD): ITGB2 mRNA
Genes: ITGB2; CD18; MFI7
Study 32802883 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 32802883 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32803633 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32803633 — Predictive Biomarker (PRD): Hormone receptor
Study 32803882 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 32803882 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 32804326 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 32804326 — Safety Biomarker (SAF): BDNF
Study 32804590 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 32804590 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study 32807084 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 32808077 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 32808163 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32808208 — Surrogate Endpoint (SUR): Blood pressure
Study 32809030 — Predictive Biomarker (PRD): MAP3K10 mRNA
Genes: MAP3K10; MLK2; MST
Study 32809217 — Predictive Biomarker (PRD): TNFRSF18 mRNA
Genes: TNFRSF18; AITR; GITR; UNQ319/PRO364
Study 32809217 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32809873 — Surrogate Endpoint (SUR): Blood pressure
Study 32809969 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study 32809969 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32811463 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 32811463 — Safety Biomarker (SAF): Platelet to lymphocyte
Study 32811969 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32811969 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32812370 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study 32813873 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 32814420 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32814465 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 32814997 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32815870 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study 32816849 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 32816891 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study 32816891 — Predictive Biomarker (PRD): CXCR3 mRNA
Genes: CXCR3; GPR9
Study 32817060 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 32817060 — Predictive Biomarker (PRD): Hormone receptor
Study 32817079 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32817460 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32817460 — Predictive Biomarker (PRD): TNFSF14 mRNA
Genes: TNFSF14; HVEML; LIGHT; UNQ391/PRO726
Study 32817593 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 32819449 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study 32819972 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32819972 — Predictive Biomarker (PRD): ICOS mRNA
Genes: ICOS; AILIM
Study 32819975 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study 32820223 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 32820223 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 32820369 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 32821007 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study 32821164 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 32821164 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32821712 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 32821712 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32821737 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32822482 — Predictive Biomarker (PRD): MYD88 mRNA
Genes: MYD88
Study 32822482 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 32822634 — Predictive Biomarker (PRD): ATXN1 mRNA
Genes: ATXN1; ATX1; SCA1
Study 32822634 — Pharmacodynamic Biomarker (PDY): Ataxin-2
Genes: ATXN2; ATX2; SCA2; TNRC13
Study 32822634 — Pharmacodynamic Biomarker (PDY): Ataxin-3
Genes: ATXN3; ATX3; MJD; MJD1; SCA3
Study 32822675 — Predictive Biomarker (PRD): PPL mRNA
Genes: PPL; KIAA0568
Study 32824392 — Predictive Biomarker (PRD): PTCHD3 mRNA
Genes: PTCHD3; PTR
Study 32827219 — Surrogate Endpoint (SUR): Serum triglycerides
Study 32827219 — Surrogate Endpoint (SUR): Blood pressure
Study 32827595 — Surrogate Endpoint (SUR): Blood pressure
Study 32829467 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32830851 — Monitoring Biomarker (MOI): Apolipoprotein A-IV
Genes: APOA4
Study 32831121 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study 32831121 — Predictive Biomarker (PRD): PLIN1 mRNA
Genes: PLIN1; PERI; PLIN
Study 32831121 — Predictive Biomarker (PRD): LHB mRNA
Genes: LHB
Study 32831121 — Predictive Biomarker (PRD): IGFBP3 mRNA
Genes: IGFBP3; IBP3
Study 32831121 — Predictive Biomarker (PRD): IL1RL2 mRNA
Genes: IL1RL2; IL1RRP2
Study 32831121 — Predictive Biomarker (PRD): NRP1 mRNA
Genes: NRP1; NRP; VEGF165R
Study 32831121 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study 32832558 — Predictive Biomarker (PRD): AIP mRNA
Genes: AIP; XAP2
Study 32834829 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 32838323 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32838323 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32838558 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 32838754 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 32839491 — Pharmacodynamic Biomarker (PDY): Gamma-Histone H2AX
Genes: H2AX; H2AFX
Study 32840736 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 32841335 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study 32841541 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study 32843374 — Surrogate Endpoint (SUR): Blood pressure
Study 32843490 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study 32843490 — Predictive Biomarker (PRD): TDO2 mRNA
Genes: TDO2; TDO
Study 32843493 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 32843493 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 32844378 — Predictive Biomarker (PRD): GCA mRNA
Genes: GCA; GCL
Study 32844399 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 32844399 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32844399 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32845475 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 32847542 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 32847746 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 32847933 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 32847973 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32849281 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 32849281 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32849914 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 32851896 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 32853332 — Surrogate Endpoint (SUR): Blood pressure
Study 32854610 — Predictive Biomarker (PRD): PYCARD mRNA
Genes: PYCARD; ASC; CARD5; TMS1
Study 32854610 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study 32854610 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 32854610 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 32856153 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 32856281 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 32856597 — Surrogate Endpoint (SUR): Blood pressure
Study 32856597 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32857176 — Predictive Biomarker (PRD): Liver iron
Study 32858478 — Surrogate Endpoint (SUR): Blood pressure
Study 32858752 — Predictive Biomarker (PRD): MPG mRNA
Genes: MPG; AAG; ANPG; MID1
Study 32860168 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32860168 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 32860168 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 32860168 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 32860168 — Predictive Biomarker (PRD): Hormone receptor
Study 32860184 — Surrogate Endpoint (SUR): Serum creatinine
Study 32860553 — Surrogate Endpoint (SUR): Blood pressure
Study 32863171 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32865097 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 32866179 — Predictive Biomarker (PRD): GCA mRNA
Genes: GCA; GCL
Study 32866219 — Surrogate Endpoint (SUR): Blood pressure
Study 32866540 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study 32866540 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 32866540 — Surrogate Endpoint (SUR): Blood pressure
Study 32867679 — Surrogate Endpoint (SUR): Blood pressure
Study 32867715 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32867715 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32867715 — Predictive Biomarker (PRD): Microsatellite instability
Study 32867715 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32867715 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 32867719 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 32867719 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32869840 — Monitoring Biomarker (MOI): HBV DNA
Study 32870250 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 32870265 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 32870265 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32870266 — Predictive Biomarker (PRD): IHH mRNA
Genes: IHH
Study 32870269 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32873343 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 32873343 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 32873924 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 32873924 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 32874376 — Surrogate Endpoint (SUR): Serum creatinine
Study 32874376 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 32874839 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study 32875289 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 32875313 — Predictive Biomarker (PRD): RAPGEF5 mRNA
Genes: RAPGEF5; GFR; KIAA0277; MRGEF
Study 32876903 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32877524 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 32877524 — Predictive Biomarker (PRD): CD37 mRNA
Genes: CD37; TSPAN26
Study 32877573 — Surrogate Endpoint (SUR): Blood pressure
Study 32877573 — Surrogate Endpoint (SUR): Serum uric acid
Study 32878566 — Surrogate Endpoint (SUR): Blood pressure
Study 32878766 — Predictive Biomarker (PRD): DKK1 mRNA
Genes: DKK1; UNQ492/PRO1008
Study 32878766 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study 32879339 — Surrogate Endpoint (SUR): Blood pressure
Study 32879938 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study 32879938 — Predictive Biomarker (PRD): CST5 mRNA
Genes: CST5
Study 32879938 — Predictive Biomarker (PRD): TNFRSF9 mRNA
Genes: TNFRSF9; CD137; ILA
Study 32881280 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 32881280 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 32881280 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 32881280 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32881280 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 32881280 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 32883871 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 32883871 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 32883871 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 32885214 — Predictive Biomarker (PRD): PRKRA mRNA
Genes: PRKRA; PACT; RAX; HSD-14; HSD14
Study 32885664 — Predictive Biomarker (PRD): DNMT3A mRNA
Genes: DNMT3A
Study 32886914 — Monitoring Biomarker (MOI): Procalcitonin
Study 32887722 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 32887722 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32888112 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32888407 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 32888407 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 32888407 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 32888407 — Predictive Biomarker (PRD): BCL6 mRNA
Genes: BCL6; BCL5; LAZ3; ZBTB27; ZNF51
Study 32889146 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 32889146 — Predictive Biomarker (PRD): B3GALT6 mRNA
Genes: B3GALT6
Study 32889146 — Predictive Biomarker (PRD): HOXA1 mRNA
Genes: HOXA1; HOX1F
Study 32889146 — Predictive Biomarker (PRD): EMX1 mRNA
Genes: EMX1
Study 32889146 — Predictive Biomarker (PRD): TSPYL5 mRNA
Genes: TSPYL5; KIAA1750
Study 32891400 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 32891715 — Predictive Biomarker (PRD): TPI1 mRNA
Genes: TPI1; TPI
Study 32893266 — Predictive Biomarker (PRD): SLC8A1 mRNA
Genes: SLC8A1; CNC; NCX1
Study 32894185 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 32894453 — Surrogate Endpoint (SUR): Blood pressure
Study 32895266 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32896211 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 32896301 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 32896640 — Predictive Biomarker (PRD): TSLP mRNA
Genes: TSLP
Study 32896640 — Predictive Biomarker (PRD): CCL17 mRNA
Genes: CCL17; SCYA17; TARC
Study 32896640 — Predictive Biomarker (PRD): CCL22 mRNA
Genes: CCL22; MDC; SCYA22; A-152E5.1
Study 32898244 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32898244 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 32898333 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 32898333 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32898333 — Predictive Biomarker (PRD): CCND1 mRNA
Genes: CCND1; BCL1; PRAD1
Study 32902099 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 32902182 — Predictive Biomarker (PRD): CARS1 mRNA
Genes: CARS1; CARS
Study 32902763 — Predictive Biomarker (PRD): TSC2
Genes: tuberin; LAM; PPP1R160
Study 32903033 — Predictive Biomarker (PRD); Safety Biomarker (SAF): STAR mRNA
Genes: STAR; STARD1
Study 32903104 — Surrogate Endpoint (SUR): Blood pressure
Study 32903199 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 32903199 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32903394 — Predictive Biomarker (PRD): DMTN mRNA
Genes: DMTN; DMT; EPB49
Study 32903623 — Predictive Biomarker (PRD): PLA2R1 mRNA
Genes: PLA2R1; CLEC13C
Study 32904642 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32904642 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study 32904642 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study 32904642 — Monitoring Biomarker (MOI): Matrix metalloproteinase 1
Genes: MMP1; CLG
Study 32904642 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study 32905581 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32905623 — Surrogate Endpoint (SUR): Blood pressure
Study 32905674 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 32910531 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32912268 — Monitoring Biomarker (MOI): HBV DNA
Study 32912364 — Surrogate Endpoint (SUR): Blood pressure
Study 32912664 — Predictive Biomarker (PRD): VEGFB mRNA
Genes: VEGFB; VRF
Study 32912664 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 32912664 — Predictive Biomarker (PRD): BCL2L1 mRNA
Genes: BCL2L1; BCL2L; BCLX
Study 32912664 — Predictive Biomarker (PRD): BAD mRNA
Genes: BAD; BBC6; BCL2L8
Study 32912664 — Predictive Biomarker (PRD): CXCR1 mRNA
Genes: CXCR1; CMKAR1; IL8RA
Study 32912664 — Predictive Biomarker (PRD): CXCR2 mRNA
Genes: CXCR2; IL8RB
Study 32912664 — Safety Biomarker (SAF): Interleukin 1 alpha
Genes: IL1A; IL1F1
Study 32912664 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 1 beta
Genes: IL1B; IL1F2
Study 32912788 — Surrogate Endpoint (SUR): Serum uric acid
Study 32913286 — Predictive Biomarker (PRD): CRTC1 mRNA
Genes: CRTC1; KIAA0616; MECT1; TORC1; WAMTP1
Study 32913985 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32913985 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 32915978 — Predictive Biomarker (PRD): ACVR1 mRNA
Genes: ACVR1; ACVRLK2
Study 32915978 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 32915978 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 32916310 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32916704 — Predictive Biomarker (PRD): AIP mRNA
Genes: AIP; XAP2
Study 32917192 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 32917537 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32917626 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 32918045 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study 32918045 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 32919458 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP